Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Mult Scler Relat Disord. 2019 Jan 10;29:15–22. doi: 10.1016/j.msard.2019.01.021

Table 2.

Location of brain lesions in MOG antibody disease.

Location involved Number of patients (n=14, %)
Deep WM 9 (64%)
Pons 8 (57%)
Cortical GM/juxtracortical WM 8 (57%)
Cerebellum 6 (43%)
Corpus callosum 6 (43%)
Midbrain 6 (43%)
Medulla 6 (43%)
Periventricular WM 5 (35.7%)
Basal ganglia 2 (14.2%)
Area postrema 1 (7%)